“…The initial approach was using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) followed by N -hydroxysuccinimide (NHS) or N -hydroxybenzotriazole (HOBt), requiring a pH of 5.5–6.0 to favor the crosslinking. , As an improvement, the coupling reagent 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM) was employed, due to its suitability to bridge the adjacent carboxylate and lysine residues under physiological conditions . To improve the crosslinking coverage and gain more protein structural information, homobifunctional crosslinkers containing amino or hydrazide with a certain crosslinking restraint were developed, such as commercial 1,6-hexanediamine (C6DA) adipic dihydrazide , or pimelic acidic dihydrazide (PDH). , Recently, a hydrazide-based crosslinker, dihydrazide sulfoxide (DHSO), was adopted to complement NHS ester-based DSSO, providing new insights into the structural dynamics of the ninth subunit in the human COP9 signalosome . In addition, a high-density crosslinking strategy was also achieved by coupling the carboxyl-selective crosslinker 2,2′-(ethylenedioxy)diethylamine with the traditional lysine-targeting crosslinker BS3, demonstrating the high precision for de novo modeling of proteasome regulatory particle architectures .…”